Rating History for Eidos Therapeutics (EIDX) by BTIG

More Stocks Rated by BTIG | Latest Ratings for EIDX
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
11/18/2020 Thomas Shrader Downgrade Neutral
(Buy)		 N/A
(N/A)		 81.21
(122.21)		 50.49% Details